Cargando…
Anti A/B Antibody Titer Rebound: Are we Making it Worse? Be Aware of Your Intravenous Immunoglobulin
Autores principales: | Kher, A., Agarwal, A., Jha, P., Bansal, D., Madken, M., Narula, A. S., Khurana, R., Kher, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146724/ https://www.ncbi.nlm.nih.gov/pubmed/30271009 http://dx.doi.org/10.4103/ijn.IJN_230_17 |
Ejemplares similares
-
Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017) -
Optimizing twice weekly dialysis-converting two-star into five-star treatment?
por: Kher, A., et al.
Publicado: (2015) -
Reusing Immunoadsorption Column – Making the ABO Incompatible Renal Transplant Affordable
por: Jha, P. K., et al.
Publicado: (2017) -
Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
por: Bansal, S. B., et al.
Publicado: (2017) -
To rebound or not to rebound
por: Stahl, Bethany A, et al.
Publicado: (2017)